These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Magnetic resonance imaging findings and clinical characteristics in mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy in a predominantly adult cohort. Mendes Coelho VC; Morita-Sherman M; Yasuda CL; Alvim MMK; Amorim BJ; Tedeschi H; Ghizoni E; Rogerio F; Cendes F Epilepsia; 2021 Jun; 62(6):1429-1441. PubMed ID: 33884614 [TBL] [Abstract][Full Text] [Related]
6. SLC35A2 somatic variants in drug resistant epilepsy: FCD and MOGHE. Elziny S; Crino PB; Winawer M Neurobiol Dis; 2023 Oct; 187():106299. PubMed ID: 37739137 [TBL] [Abstract][Full Text] [Related]
7. Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Frontal Lobe Epilepsy: A New Clinico-Pathological Entity. Schurr J; Coras R; Rössler K; Pieper T; Kudernatsch M; Holthausen H; Winkler P; Woermann F; Bien CG; Polster T; Schulz R; Kalbhenn T; Urbach H; Becker A; Grunwald T; Huppertz HJ; Gil-Nagel A; Toledano R; Feucht M; Mühlebner A; Czech T; Blümcke I Brain Pathol; 2017 Jan; 27(1):26-35. PubMed ID: 26748554 [TBL] [Abstract][Full Text] [Related]
8. Somatic SLC35A2 variants in the brain are associated with intractable neocortical epilepsy. Winawer MR; Griffin NG; Samanamud J; Baugh EH; Rathakrishnan D; Ramalingam S; Zagzag D; Schevon CA; Dugan P; Hegde M; Sheth SA; McKhann GM; Doyle WK; Grant GA; Porter BE; Mikati MA; Muh CR; Malone CD; Bergin AMR; Peters JM; McBrian DK; Pack AM; Akman CI; LaCoursiere CM; Keever KM; Madsen JR; Yang E; Lidov HGW; Shain C; Allen AS; Canoll PD; Crino PB; Poduri AH; Heinzen EL Ann Neurol; 2018 Jun; 83(6):1133-1146. PubMed ID: 29679388 [TBL] [Abstract][Full Text] [Related]
9. Mild malformation of cortical development with oligodendroglial hyperplasia and epilepsy (MOGHE): a widespread disease with an apparently focal epilepsy. Seetharam R; Nooraine J; Mhatre R; Ramachandran J; Iyer RB; Mahadevan A Epileptic Disord; 2021 Apr; 23(2):407-411. PubMed ID: 33935026 [TBL] [Abstract][Full Text] [Related]
10. Loss of Slc35a2 alters development of the mouse cerebral cortex. Elziny S; Sran S; Yoon H; Corrigan RR; Page J; Ringland A; Lanier A; Lapidus S; Foreman J; Heinzen EL; Iffland P; Crino PB; Bedrosian TA Neurosci Lett; 2024 Jul; 836():137881. PubMed ID: 38909838 [TBL] [Abstract][Full Text] [Related]
11. Multifocal mild malformation of cortical development with oligodendroglial hyperplasia (MOGHE) associated with SLC35A2 brain mosaicism. Xu S; Xu J; Chen C; Ye L; Wang S; Miao P; Zhu J Clin Neurophysiol; 2023 Jan; 145():22-25. PubMed ID: 36399943 [No Abstract] [Full Text] [Related]
12. D-galactose Supplementation for the Treatment of Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE): A Pilot Trial of Precision Medicine After Epilepsy Surgery. Aledo-Serrano Á; Valls-Carbó A; Fenger CD; Groeppel G; Hartlieb T; Pascual I; Herraez E; Cabal B; García-Morales I; Toledano R; Budke M; Beltran-Corbellini Á; Baldassari S; Coras R; Kobow K; Herrera DM; Del Barrio A; Dahl HA; Del Pino I; Baulac S; Blumcke I; Møller RS; Gil-Nagel A Neurotherapeutics; 2023 Sep; 20(5):1294-1304. PubMed ID: 37278968 [TBL] [Abstract][Full Text] [Related]
13. Clinical Features, Neuropathology, and Surgical Outcome in Patients With Refractory Epilepsy and Brain Somatic Variants in the Barba C; Blumcke I; Winawer MR; Hartlieb T; Kang HC; Grisotto L; Chipaux M; Bien CG; Heřmanovská B; Porter BE; Lidov HGW; Cetica V; Woermann FG; Lopez-Rivera JA; Canoll PD; Mader I; D'Incerti L; Baldassari S; Yang E; Gaballa A; Vogel H; Straka B; Macconi L; Polster T; Grant GA; Krsková L; Shin HJ; Ko A; Crino PB; Krsek P; Lee JH; Lal D; Baulac S; Poduri A; Guerrini R; Neurology; 2023 Jan; 100(5):e528-e542. PubMed ID: 36307217 [TBL] [Abstract][Full Text] [Related]
14. Clinical and histopathological outcomes in patients with SCN1A mutations undergoing surgery for epilepsy. Skjei KL; Church EW; Harding BN; Santi M; Holland-Bouley KD; Clancy RR; Porter BE; Heuer GG; Marsh ED J Neurosurg Pediatr; 2015 Dec; 16(6):668-74. PubMed ID: 26339958 [TBL] [Abstract][Full Text] [Related]
15. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study. Baldassari S; Ribierre T; Marsan E; Adle-Biassette H; Ferrand-Sorbets S; Bulteau C; Dorison N; Fohlen M; Polivka M; Weckhuysen S; Dorfmüller G; Chipaux M; Baulac S Acta Neuropathol; 2019 Dec; 138(6):885-900. PubMed ID: 31444548 [TBL] [Abstract][Full Text] [Related]
16. Frontal Disconnection for Treating Mild Malformation of Cortical Development with Oligodendroglial Hyperplasia in Epilepsy (MOGHE) in the Frontal Lobe. Wang Y; Liu Q; Yu H; Liu C; Sun Y; Wang Y; Liu X; Cai L J Vis Exp; 2024 Aug; (210):. PubMed ID: 39221950 [TBL] [Abstract][Full Text] [Related]
20. Identification of a mosaic MTOR variant in purified neuronal DNA in a patient with focal cortical dysplasia using a novel depth electrode harvesting technique. Klein KM; Mascarenhas R; Merrikh D; Khanbabaei M; Maroilley T; Kaur N; Liu Y; Soule T; Manalo M; Tamura G; Jacobs J; Hader W; Pfeffer G; Tarailo-Graovac M Epilepsia; 2024 Jun; 65(6):1768-1776. PubMed ID: 38587282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]